Minnesota Legislators Target Private Equity in Autism Therapy Amid Alarming Reports of Exploitation and Harm

Senators Mohamed and Dibble Propose Sweeping Reforms to Safeguard Vulnerable Children and Public Funds After Damning Investigation Reveals Profiteering and Questionable Efficacy of Applied Behavior Analysis.

The Unveiling: A Call for Reform in Minnesota

Legislative Action Sparked by Investigative Journalism

MINNEAPOLIS, MN – A groundbreaking investigation by "The 74 Million," an education news organization, has ignited a legislative firestorm in Minnesota, prompting two prominent state senators to announce their intent to introduce laws aimed at curbing the pervasive influence of private equity investment firms on autism therapy providers. The report, which meticulously detailed how Wall Street interests have increasingly capitalized on a vital healthcare sector, has drawn sharp criticism and renewed calls for greater oversight and accountability.

State Senator Zaynab Mohamed (DFL-Minneapolis), reacting to the investigation’s findings, expressed profound indignation. “This report is outrageous,” Senator Mohamed declared, her voice resonating with a mix of anger and determination. “The idea that Wall Street investors are exploiting these programs for profit is infuriating. Our most vulnerable children and their families deserve care that is driven by medical necessity and compassion, not by quarterly earnings reports.” Her sentiments were echoed by her colleague, State Senator Scott Dibble (DFL-Minneapolis), who has long advocated for transparency and ethical practices within the healthcare industry. Together, they are poised to introduce legislation designed to rein in what they describe as unchecked profiteering that often comes at the expense of patient well-being.

The Crisis in Autism Therapy: A Deep Dive

The core of the issue, as highlighted by "The 74 Million" investigation, lies in the dramatic shift in ownership and operational philosophy within the applied behavior analysis (ABA) therapy sector. Over the past decade, private equity firms, largely operating under limited regulatory scrutiny, have embarked on an aggressive acquisition spree. They have systematically purchased hundreds of independent, often family-run, autism therapy centers across the nation, including a significant number in Minnesota. These disparate "mom-and-pop" operations have subsequently been consolidated into sprawling, lucrative networks, fundamentally transforming the landscape of autism care from a localized, community-based service into a highly centralized, profit-driven enterprise.

This consolidation has coincided with an explosive increase in Medicaid reimbursements for ABA therapy. What began as approximately $400 million in national reimbursements in 2019 skyrocketed to nearly $2 billion by 2024, according to "The 74 Million" analysis. This five-fold increase in just five years raises serious questions about the sustainability of public funding and the motivations behind such rapid expansion.

A Decade of Disruption: Private Equity’s Infiltration of ABA

The Rise of For-Profit Chains

The business model employed by private equity firms is straightforward yet impactful: identify industries with stable revenue streams, acquire existing businesses, streamline operations (often by cutting costs in staffing or patient-to-therapist ratios), maximize short-term profits, and then sell the consolidated entity for a significant return. In the context of autism therapy, this has meant transforming a healthcare service into an attractive investment opportunity. Firms are drawn to the sector by the growing demand for autism services and the availability of consistent government funding through Medicaid and private insurance mandates.

The investigation revealed that this strategy has been incredibly successful for investors. A meticulous analysis of U.S. Centers for Medicare and Medicaid records by "The 74 Million" uncovered that private equity firms now own almost half of the top 50 companies with the highest claims for ABA services. These firms alone accounted for a staggering $3.1 billion of the nearly $7 billion billed during the six-year investigative window, underscoring their dominant financial footprint in the industry.

Medicaid Reimbursements Soar Amidst Scrutiny

The sheer volume of Medicaid reimbursements channeled towards these private equity-owned entities has naturally invited intense scrutiny. While increased access to therapy for autistic children is a laudable goal, the rapid escalation of costs without commensurate improvements in transparency or demonstrable outcomes has raised red flags for policymakers and patient advocates alike. Critics argue that the profit imperative of private equity often conflicts with the ethical imperative of patient care, leading to potential compromises in service quality, therapist training, and overall effectiveness. The concern is that public funds intended to support vulnerable populations are instead enriching distant investors, with little accountability for the quality of care delivered.

The Questionable Efficacy and Harmful Impact of ABA

Beyond the financial implications, "The 74 Million" investigation delved into a more troubling aspect: the very nature and effectiveness of applied behavior analysis itself. Building on prior reporting, the investigation highlighted the "weak evidence base" supporting ABA, particularly in its more intensive forms. ABA, a behavioral conditioning therapy often administered to autistic children as young as two years old for up to 40 hours a week, is designed to "extinguish" autistic traits through a system of rewards and punishments. Historically, it has been the dominant intervention for autism, often presented as the only path to integrate autistic individuals into neurotypical society.

However, a growing body of recent research and firsthand accounts from autistic adults and their families challenge this long-held paradigm. These studies have uncovered heightened rates of Post-Traumatic Stress Disorder (PTSD) and psychiatric hospitalizations among individuals who underwent intensive ABA therapy in their childhood. Critics argue that by focusing on suppressing natural autistic behaviors rather than fostering communication and coping skills, ABA can be deeply traumatizing, forcing children to mask their true selves and internalize the message that their natural way of being is "wrong." This perspective aligns with the burgeoning neurodiversity movement, which advocates for accepting autism as a natural variation of human neurology rather than a disorder to be "cured." The revelations about the potential psychological harm inflicted by ABA, combined with the financial exploitation, present a double-edged crisis for families seeking support.

Minnesota: A Lucrative Market Under Threat

Why Minnesota Attracted Big Players

Minnesota, known for its robust social services and commitment to healthcare access, has historically been an attractive market for healthcare providers. Like a handful of other states that have diligently worked to make services accessible to as many families with disabled children as possible, Minnesota’s generous Medicaid reimbursement rates and comprehensive benefits have made it a prime target for the industry’s largest for-profit players. As private equity entered the picture, large providers frequently migrated out of states with lower Medicaid reimbursement rates and into more lucrative ones like Minnesota, further consolidating their market power and influence.

The Broader Landscape of Medicaid Fraud and Waste

The issues in Minnesota are not isolated but reflect a broader national concern regarding fraud, waste, and abuse within the Medicaid system. Over the past year, scandals involving these issues in autism therapy reimbursements have erupted across the country. Minnesota, in particular, has found itself under the spotlight, even drawing the ire of the previous Trump administration. Last winter, the administration controversially justified a violent Immigration and Customs Enforcement (ICE) incursion into the Twin Cities by claiming it was necessary to root out Medicaid abuse allegedly perpetrated by immigrants. This politicized narrative, however, often overshadowed the systemic issues of corporate profiteering.

In February, the Department of Government Efficiency released a massive 275 million-record Medicaid dataset, ostensibly to combat waste, fraud, and abuse. Yet, "The 74 Million’s" analysis of this very data pointed to a different, more pervasive systemic problem: the unchecked profiteering and glaring lack of state and federal oversight of ABA services, exacerbated by the rapid acquisition of providers by private equity firms. This underscores that while individual instances of fraud exist, the larger financial drain on public resources stems from a flawed regulatory framework that permits aggressive, profit-first business models in critical healthcare sectors.

The "One Big Beautiful Bill Act" and Its Pressures

The urgency for reform in Minnesota is further amplified by the recent passage of the "One Big Beautiful Bill Act," which is slated to significantly slash Medicaid spending. In an era of shrinking budgets, the imperative to ensure that every public dollar is spent efficiently and ethically becomes paramount. Senator Mohamed and Senator Dibble contend that as states grapple with maintaining essential children’s benefits amidst these cuts, it becomes even more critical to identify and eliminate wasteful spending and exploitative practices. The current system, they argue, is simply unsustainable and unjust, making immediate legislative intervention a necessity to safeguard both public funds and the welfare of children.

Legislators Propose Comprehensive Safeguards

Demands for Transparency and Accountability

In response to these multifaceted challenges, Senators Mohamed and Dibble are championing a package of legislative proposals designed to introduce unprecedented levels of transparency and accountability into the autism therapy sector. At the heart of their initiative is the demand for transparent reporting of who truly owns autism services centers. This mandate would peel back the layers of corporate structures, often obscured by shell companies and holding firms, to reveal the ultimate beneficiaries of Medicaid reimbursements.

Furthermore, their legislation seeks to empower the state with the authority to "weed out" providers whose business models are demonstrably profit-driven to the detriment of children’s care. This could involve stricter licensing requirements, performance audits, and the ability to revoke licenses from entities that consistently prioritize financial gain over patient outcomes. The goal is to shift the focus back to patient-centric care, ensuring that therapeutic decisions are guided by medical best practices rather than financial incentives.

Learning from Past Failures: The Nursing Home Parallel

Senator Dibble brings a wealth of experience to this legislative effort, having previously encountered similar issues in other healthcare sectors. Last year, he authored a bill that sought to mandate disclosure of ownership for nursing home and assisted living facilities acquired by for-profit companies. Although that bill ultimately did not pass into law, the parallels between the challenges in long-term care and autism therapy are striking and serve as a cautionary tale.

A recent investigation by state healthcare monitors into Minnesota’s long-term care facilities revealed that a staggering 79% of complaints regarding abuse and neglect involved for-profit companies. This alarming statistic underscores a systemic problem: when patient care suffers due to profit motives, the lack of clarity regarding a company’s true ownership makes it incredibly difficult to assign responsibility and hold anyone accountable. Dibble and other critics contend that this opacity allows private equity firms to evade consequences for poor performance, ultimately harming vulnerable patients. The proposed legislation for autism therapy aims to prevent a similar crisis from fully engulfing another critical care sector.

A Call for Public Trust and Patient-Centric Care

Senator Dibble passionately articulated the need for a higher standard of accountability. “It’s not enough to have a P.O. box in New Jersey,” he stated, referring to the common practice of remote corporate ownership. “I think we’re entitled to know — this particular entity, what else do they own, and how well have they provided services?” He drew a compelling analogy to other regulated industries: “Before someone can come in and purchase a liquor license, they need to prove that they’re an outstanding citizen who hasn’t participated in any shady practices and they can be entrusted with the public trust that a publicly issued license entails.” This comparison highlights the perceived disparity in oversight, where a business selling alcohol faces more rigorous scrutiny than one providing critical therapy to children with autism.

In addition to transparency, the senators are pushing for a requirement that providers allocate a specific minimum percentage of the Medicaid reimbursements they receive directly to patient care. This measure is designed to prevent excessive administrative costs, executive compensation, or shareholder dividends from siphoning off funds that should be directly invested in therapy, qualified staff, and facility improvements. “This kind of aggressive super-sized profit motive is totally inappropriate in these settings because it incentivizes behaviors that don’t support the public’s interest and good use of public dollars,” Dibble emphasized, underscoring the ethical imperative to safeguard public funds and ensure they benefit the intended recipients.

The Far-Reaching Implications of Unchecked Profiteering

The Human Cost: Disrupted Care and Vulnerable Families

The consequences of unchecked private equity involvement extend far beyond financial mismanagement. When private equity firms have extracted their desired cash flow and moved on, the remaining debt often leaves the acquired healthcare providers bankrupt or severely hampered in their ability to deliver services. For families reliant on these centers for crucial autism therapy, such closures are devastating. Children often experience abrupt disruptions in their treatment plans, losing established therapists and routines, which can be particularly distressing and regressive for autistic individuals who thrive on consistency. Families are frequently left scrambling to find new providers, facing long waiting lists and the emotional toll of uncertainty, all while their children’s development and well-being hang in the balance. This human cost, often invisible in financial reports, is a central driver behind the proposed legislative reforms.

Protecting Public Dollars: A Fiduciary Duty

Beyond the immediate impact on families, the issue of private equity in autism therapy raises fundamental questions about the responsible stewardship of public funds. Medicaid, a lifeline for millions of vulnerable Americans, is funded by taxpayers. When these funds are diverted from direct patient care to enrich private investors, it constitutes a breach of public trust and a failure of fiduciary duty. The proposed legislation seeks to reassert the state’s role in ensuring that public dollars are utilized for their intended purpose: to provide high-quality, ethical care to those who need it most, rather than fueling speculative investments.

Shaping the Future of Autism Services

The legislative battle in Minnesota holds broader implications for the future of autism services across the United States. If successful, these reforms could serve as a blueprint for other states grappling with similar challenges, potentially catalyzing a national movement towards greater regulation of private equity in healthcare. It could also encourage a critical re-evaluation of ABA therapy itself, prompting a shift towards more individualized, evidence-based, and neurodiversity-affirming interventions that prioritize the well-being and autonomy of autistic individuals.

Looking Ahead: The Battle for Ethical Healthcare

The Legislative Path Forward

Senators Mohamed and Dibble are preparing to introduce their bills in the upcoming legislative session. Their success will depend on their ability to garner bipartisan support, educate their colleagues on the complexities of private equity financing and autism therapy, and mobilize public and advocacy group pressure. The opposition from powerful industry lobbyists, representing private equity interests, is expected to be significant, making this a challenging but crucial legislative fight.

A National Conversation on Healthcare Investment

The Minnesota initiative transcends state borders, contributing to a growing national conversation about the ethical boundaries of private investment in essential public services. From nursing homes to emergency rooms and now autism therapy, the pattern of private equity prioritizing profits over people is becoming increasingly apparent. The proposed reforms in Minnesota represent a critical step towards asserting that certain sectors, particularly those involving the care of vulnerable populations, cannot be treated as mere commodities for financial speculation. The outcome of this legislative effort in Minnesota will be closely watched, as it could set a powerful precedent for how states can protect their citizens and their public funds from the unchecked forces of corporate greed.